PROFUND ADVISORS LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 292 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$831,758
-40.6%
32,003
-34.6%
0.03%
-43.6%
Q1 2024$1,400,256
-28.0%
48,960
-23.0%
0.06%
-34.5%
Q4 2023$1,944,722
+34.2%
63,553
+17.9%
0.08%
+5.0%
Q3 2023$1,448,750
-13.7%
53,917
+14.5%
0.08%
-11.1%
Q2 2023$1,679,122
+25.2%
47,087
-10.8%
0.09%
+8.4%
Q1 2023$1,341,171
+83.7%
52,802
+193.4%
0.08%
+76.6%
Q4 2022$730,039
+26.3%
17,999
+3.0%
0.05%
+11.9%
Q3 2022$578,000
-7.7%
17,476
-1.8%
0.04%
+5.0%
Q2 2022$626,000
-33.1%
17,792
-12.6%
0.04%
+2.6%
Q1 2022$936,000
-37.0%
20,359
-9.2%
0.04%
-20.4%
Q4 2021$1,486,000
-4.4%
22,412
-10.0%
0.05%
-5.8%
Q3 2021$1,554,000
+121.4%
24,899
+193.7%
0.05%
+116.7%
Q2 2021$702,000
+21.5%
8,479
-2.8%
0.02%
+9.1%
Q1 2021$578,000
-23.8%
8,720
-11.9%
0.02%
-33.3%
Q4 2020$759,000
+90.2%
9,893
+6.8%
0.03%
+57.1%
Q3 2020$399,000
+56.5%
9,266
+56.8%
0.02%
+50.0%
Q2 2020$255,000
-57.7%
5,909
-37.9%
0.01%
-46.2%
Q4 2019$603,000
+123.3%
9,514
-0.6%
0.03%
+85.7%
Q3 2019$270,000
+9.8%
9,568
+3.0%
0.01%
+16.7%
Q2 2019$246,0009,2900.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$93,815,00051.06%
Aquilo Capital Management, LLC 436,514$12,559,0004.90%
Vivo Capital, LLC 768,674$22,115,0002.00%
ACUTA CAPITAL PARTNERS, LLC 109,700$3,156,0001.53%
Prosight Management, LP 104,737$3,013,0001.41%
Capital Impact Advisors, LLC 84,537$2,432,0001.02%
Artal Group S.A. 600,000$17,262,0000.73%
HUSSMAN STRATEGIC ADVISORS, INC. 62,000$1,784,0000.48%
Quantitative Investment Management, LLC 150,401$4,327,0000.47%
OAK RIDGE INVESTMENTS LLC 131,502$3,784,0000.39%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders